Emaediong I. Akpanekpo

Dr. Emaediong I. Akpanekpo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in BMJ Mental Health
Verified
Journal Article
Open access
PDF file
EAEmaediong I. Akpanekpo
Emaediong I. Akpanekpo
AKAzar Kariminia
Azar Kariminia
PSPreeyaporn Srasuebkul
Preeyaporn Srasuebkul
JTJulian N Trollor
Julian N Trollor
DGDavid Greenberg
David Greenberg
TBTony Butler
Tony Butler
Background Mental health services are available for young people involved with the criminal justice system. However, they have unmet mental health needs after the expiration of criminal justice supervision. Objective To determine the incidence rate and identify predictors of psychiatric hospitalisations within 24 months after the expiration of criminal justice supervision among young people involved with the New South Wales (NSW) criminal justice system. Methods Retrospective data from 1556 individuals aged 14–22 years who participated in four surveys of justice-involved young people in NSW were harmonised and linked to four NSW data collections. We calculated the incidence rates of psychiatric hospitalisations within 24 months postsupervision and identified predictors of these hospitalisations using a competing risks regression analysis. Results Within 24 months postsupervision, 11.4% had a psychiatric hospitalisation compared with 3.5% during supervision. 20.7% of those admitted had a known history of mental illness and engaged with community-based and outpatient mental health services postsupervision. Predictors of psychiatric hospitalisations were: female sex (adjusted subdistribution HR (asHR) 1.84, 95% CI 1.24 to 2.73); previous incarceration (highest asHR for ≥4 episodes 1.67, 95% CI 1.01 to 2.78); head injury (asHR 1.63, 95% CI 1.20 to 2.21); personality disorder (asHR 3.66, 95% CI 2.06 to 6.48) and alcohol and substance use disorder (asHR 1.89, 95% CI 1.29 to 2.77). Conclusion Justice-involved youth have higher rates of psychiatric admissions after criminal justice supervision. Engagement with mental health services postsupervision is important in addressing emerging or persisting mental health needs.

1 August 2025 in Psychiatric Services
Verified
Journal Article
Closed access
EAEmaediong I. Akpanekpo
Emaediong I. Akpanekpo
PSPreeyaporn Srasuebkul
Preeyaporn Srasuebkul
TBTony Butler
Tony Butler
JTJulian Norman Trollor
Julian Norman Trollor
JKJohn Kasinathan
John Kasinathan
AKAzar Kariminia
Azar Kariminia

25 April 2025 in International Journal of Law and Psychiatry
Verified
Journal Article
Open access
EAEmaediong I. Akpanekpo
Emaediong I. Akpanekpo
TBTony Butler
Tony Butler
PSPreeyaporn Srasuebkul
Preeyaporn Srasuebkul
JTJulian N. Trollor
Julian N. Trollor
JKJohn Kasinathan
John Kasinathan
AKAzar Kariminia
Azar Kariminia
Mental health disorders and adverse childhood experiences (ACEs) are known risk factors for youth offending. However, most studies operationalize these factors as static and fail to distinguish between isolated reoffences and escalating patterns of criminal behaviour. The impact of mental health service engagement on interrupting cyclical, repetitive offending also remains unclear. We linked offending records (1994-2022) and mental health records (2001-2022) for 1556 justice-involved youth in New South Wales, Australia. The Prentice, Williams, and Peterson Gap Time model with time-varying effects was used to identify factors associated with accelerated reoffending during a five-year follow-up. The median age at first conviction was 15 years for custody-supervised youth and 16 years for community-supervised youth. Among custody-supervised youth aged 14 to 17, the prevalence of ACEs, mental health disorders, and their co-occurrence were 69.6 %, 33.9 %, and 26.5 %, respectively, compared to 42.5 %, 30.8 %, and 14.8 % for community-supervised youth. Recurrent offences occurred in 64.8 % of custody-supervised youth and 52.1 % of community-supervised youth. Age, physical neglect, substance use disorders, and personality disorders demonstrated time-varying effects on reoffending risk. Additional risk factors included physical abuse, parental death, anxiety disorders, mood disorders, and previous incarceration. Mental health service contact was associated with reduced reoffending risk. This study demonstrates the dynamic nature of criminogenic risk factors and the protective effect of mental health service engagement. Youth justice policymakers should prioritize regular mental health assessments and improved access to interventions for justice-involved youth to reduce recurrent offending and enhance public safety.

30 July 2025 in Schizophrenia Research
Verified
Journal Article
Open access
EAEmaediong I. Akpanekpo
Emaediong I. Akpanekpo
NCNabila Z. Chowdhury
Nabila Z. Chowdhury
TBTony Butler
Tony Butler
Justice-involved youth with psychosis have an increased risk of reoffending, but the impact of early, non-mandated mental health service engagement on recidivism is underexplored. This study examined whether non-mandated mental health service contact within 90 days of an index offense is associated with reduced reoffending in this population. This cohort study analyzed data from 386 justice-involved youth diagnosed with psychosis between 2001 and 2021. The primary exposure was mental health service contact within 90 days post-offense. The primary outcome was time to reoffending within a 24-month follow-up period. Cox proportional hazards regression estimated adjusted hazard ratios (aHR) and 95 % confidence intervals (CI), adjusting for demographic, clinical, and justice-related factors. Among the cohort (median age: 16 years), 54.9 % had contact with mental health services within 90 days of the index offense. The cumulative incidence of any reoffending was lower in those with mental health service contact (53.1 %) compared to those without (73.5 %), as was violent reoffending (40.4 % vs. 52.4 %). Youth with substance-related psychoses had the highest reoffending rate (70.8 %), followed by those with schizophrenia-related psychoses (62.7 %), while youth with affective psychoses had the lowest rate (29.4 %). Mental health service contact was associated with a lower hazard of any (aHR: 0.59, 95 % CI: 0.43-0.82) and violent (aHR: 0.68, 95 % CI: 0.49-0.96) reoffending. Early engagement with mental health services is associated with reduced reoffending risk among justice-involved youth with psychosis. Improving access to timely mental health care should be a priority in this high-risk population.

27 November 2025 in eClinicalMedicine
Verified
Journal Article
Open access
TBTony Butler
Tony Butler
EAEmaediong I. Akpanekpo
Emaediong I. Akpanekpo
LKLee Knight
Lee Knight
KRKristy Robledo
Kristy Robledo
DGDavid Greenberg
David Greenberg
PSPeter W. Schofield
Peter W. Schofield
Biological studies suggest serotonin modulation via selective serotonin reuptake inhibitors (SSRIs) might reduce impulsive violence, however, robust evidence in offender populations is limited. We aimed to determine whether sertraline reduces violent reoffending compared with placebo in highly impulsive men with recurrent violent offending. We conducted a double-blind, placebo-controlled, randomised clinical trial in community settings in New South Wales, Australia. Eligible participants were men aged 18 years or older with ≥2 prior violent convictions and a Barratt Impulsiveness Scale score ≥70. Following a 4-week single-blind active run-in phase with sertraline, participants were randomly assigned (1:1, minimization stratified by key factors) to receive oral sertraline (100 mg daily) or matching placebo for 12 months. The primary outcome was the first convicted violent offence within 12 months, assessed via linkage to the state Reoffending Database. The primary analysis followed the intention-to-treat principle. The trial is registered with ANZCTR (ACTRN12613000442707) and is closed to new participants. Between October 28, 2013, and July 13, 2021, 630 eligible men were randomly assigned: 319 to sertraline and 311 to placebo. By 12 months, only 204 participants remained engaged with the study. All participants were included in the primary analysis. A primary outcome event (violent offence within 12 months) occurred in 72 (22.6%) of 319 participants assigned sertraline and 70 (22.5%) of 311 assigned placebo (Relative Risk 1.00, 95% CI 0.75–1.34; p = 0.99). Serious adverse events occurred in 22 (6.9%) participants receiving sertraline and 29 (9.3%) receiving placebo. Sertraline did not significantly reduce the risk of violent reoffending compared with placebo. Post-hoc analyses suggested a possible selective effect on domestic violence offending. Initial funding for the ReINVEST trial was provided from an Australian National Health and Medical Research Council partnership grant No. 533559. From 2018, subsequent funding was provided by the 10.13039/501100025174 NSW Department of Communities and Justice .

17 November 2023 in Trials
Verified
Journal Article
Open access
PDF file
NDNatalie Doring
Natalie Doring
YHYe In (Jane) Hwang
Ye In (Jane) Hwang
EAEmaediong I. Akpanekpo
Emaediong I. Akpanekpo
MGMathew Gullotta
Mathew Gullotta
BTBianca Ton
Bianca Ton
TBTony Butler
Tony Butler
Preventing dropout (attrition) from clinical trials is vital for improving study validity. Dropout is particularly important in justice-involved populations as they can be very challenging to engage and recruit in the first instance. This study identifies factors associated with dropout in a double-blind, placebo-controlled randomised control trial of a selective serotonin reuptake inhibitor (SSRI) aimed at reducing reoffending in highly impulsive men with histories of violent offending. Age, education, social support, psychiatric history, and length of previous incarceration were identified as factors that predict attrition. These findings are consistent with previous research examining variables associated with attrition in clinical trials for community and offender populations. We also explored referral source and treatment allocation as attrition predictors. Although neither significantly predicted attrition, we identified that there are discernible differences in the median time to attrition among the referral source subgroups. Understanding factors that predict treatment completion and attrition will allow researchers to identify participants for whom additional provisions may optimise retention and inform development of targeted interventions.